Could Generics be the hot ticket in the healthcare sector.?Although the bio-techs and healthcare ar large has had a correction recently , the impetus seems to be the run away pricing of new and old patented brand drugs... Companies like Valaent and Concordia are right at the centre of this .... they have a history of buying drug rights and raising prices but society can only pay so much so this can and has back fired on those companies...Unfortunately the sell off was indiscriminate and wide spread across the healthcare indiustry... In the future However, smart investment , government and other stakeholders will realize this is throwing the baby out with the bath water in the sense that generics drug companies are a direct help, to the problem beimg addressed....lowering drug costs to society...This is why I think what seems to be an undertoe in the healthcare sector will likely end up being very supportive to generics and NPH's business (when sound minds prevail)..